vs

Side-by-side financial comparison of GRAIL, Inc. (GRAL) and OneSpan Inc. (OSPN). Click either name above to swap in a different company.

OneSpan Inc. is the larger business by last-quarter revenue ($65.9M vs $43.6M, roughly 1.5× GRAIL, Inc.). OneSpan Inc. runs the higher net margin — 17.5% vs -227.5%, a 245.0% gap on every dollar of revenue. On growth, GRAIL, Inc. posted the faster year-over-year revenue change (14.0% vs 4.1%). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs 4.0%).

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.

OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.

GRAL vs OSPN — Head-to-Head

Bigger by revenue
OSPN
OSPN
1.5× larger
OSPN
$65.9M
$43.6M
GRAL
Growing faster (revenue YoY)
GRAL
GRAL
+9.9% gap
GRAL
14.0%
4.1%
OSPN
Higher net margin
OSPN
OSPN
245.0% more per $
OSPN
17.5%
-227.5%
GRAL
Faster 2-yr revenue CAGR
GRAL
GRAL
Annualised
GRAL
27.7%
4.0%
OSPN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GRAL
GRAL
OSPN
OSPN
Revenue
$43.6M
$65.9M
Net Profit
$-99.2M
$11.6M
Gross Margin
73.6%
Operating Margin
-285.4%
22.5%
Net Margin
-227.5%
17.5%
Revenue YoY
14.0%
4.1%
Net Profit YoY
-2.2%
EPS (diluted)
$-2.37
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRAL
GRAL
OSPN
OSPN
Q1 26
$65.9M
Q4 25
$43.6M
$62.9M
Q3 25
$36.2M
$57.1M
Q2 25
$35.5M
$59.8M
Q1 25
$31.8M
$63.4M
Q4 24
$38.3M
$61.2M
Q3 24
$28.7M
$56.2M
Q2 24
$32.0M
$60.9M
Net Profit
GRAL
GRAL
OSPN
OSPN
Q1 26
$11.6M
Q4 25
$-99.2M
$43.5M
Q3 25
$-89.0M
$6.5M
Q2 25
$-114.0M
$8.3M
Q1 25
$-106.2M
$14.5M
Q4 24
$-97.1M
$28.8M
Q3 24
$-125.7M
$8.3M
Q2 24
$-1.6B
$6.6M
Gross Margin
GRAL
GRAL
OSPN
OSPN
Q1 26
73.6%
Q4 25
73.6%
Q3 25
73.6%
Q2 25
73.5%
Q1 25
74.3%
Q4 24
74.0%
Q3 24
73.9%
Q2 24
66.2%
Operating Margin
GRAL
GRAL
OSPN
OSPN
Q1 26
22.5%
Q4 25
-285.4%
19.9%
Q3 25
-346.2%
14.4%
Q2 25
-446.9%
17.6%
Q1 25
-482.5%
27.1%
Q4 24
-358.0%
19.3%
Q3 24
-640.5%
20.0%
Q2 24
-5133.8%
12.5%
Net Margin
GRAL
GRAL
OSPN
OSPN
Q1 26
17.5%
Q4 25
-227.5%
69.2%
Q3 25
-245.8%
11.4%
Q2 25
-320.7%
13.9%
Q1 25
-333.6%
22.9%
Q4 24
-253.8%
47.1%
Q3 24
-438.7%
14.7%
Q2 24
-4958.8%
10.8%
EPS (diluted)
GRAL
GRAL
OSPN
OSPN
Q1 26
$0.39
Q4 25
$-2.37
$1.13
Q3 25
$-2.46
$0.17
Q2 25
$-3.18
$0.21
Q1 25
$-3.10
$0.37
Q4 24
$-1.49
$0.73
Q3 24
$-3.94
$0.21
Q2 24
$-51.06
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRAL
GRAL
OSPN
OSPN
Cash + ST InvestmentsLiquidity on hand
$249.7M
$49.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.6B
$272.0M
Total Assets
$2.9B
$383.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRAL
GRAL
OSPN
OSPN
Q1 26
$49.8M
Q4 25
$249.7M
$70.5M
Q3 25
$126.9M
$85.6M
Q2 25
$127.4M
$92.9M
Q1 25
$133.9M
$105.2M
Q4 24
$214.2M
$83.2M
Q3 24
$853.6M
$77.5M
Q2 24
$958.8M
$63.8M
Stockholders' Equity
GRAL
GRAL
OSPN
OSPN
Q1 26
$272.0M
Q4 25
$2.6B
$271.8M
Q3 25
$2.2B
$238.3M
Q2 25
$2.3B
$242.5M
Q1 25
$2.4B
$231.1M
Q4 24
$2.5B
$212.5M
Q3 24
$2.6B
$194.6M
Q2 24
$2.7B
$178.6M
Total Assets
GRAL
GRAL
OSPN
OSPN
Q1 26
$383.1M
Q4 25
$2.9B
$397.7M
Q3 25
$2.6B
$343.5M
Q2 25
$2.7B
$357.1M
Q1 25
$2.8B
$333.8M
Q4 24
$3.0B
$338.7M
Q3 24
$3.1B
$289.3M
Q2 24
$3.3B
$286.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRAL
GRAL
OSPN
OSPN
Operating Cash FlowLast quarter
$-63.8M
$28.2M
Free Cash FlowOCF − Capex
$-63.9M
FCF MarginFCF / Revenue
-146.5%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
2.44×
TTM Free Cash FlowTrailing 4 quarters
$-299.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRAL
GRAL
OSPN
OSPN
Q1 26
$28.2M
Q4 25
$-63.8M
$12.6M
Q3 25
$-63.2M
$11.3M
Q2 25
$-77.0M
$6.2M
Q1 25
$-95.0M
$29.4M
Q4 24
$12.4M
Q3 24
$-104.6M
$14.0M
Q2 24
$-171.8M
$2.3M
Free Cash Flow
GRAL
GRAL
OSPN
OSPN
Q1 26
Q4 25
$-63.9M
$9.6M
Q3 25
$-63.6M
$8.8M
Q2 25
$-77.3M
$4.4M
Q1 25
$-95.1M
$27.7M
Q4 24
$10.5M
Q3 24
$-105.6M
$12.0M
Q2 24
$-173.2M
$26.0K
FCF Margin
GRAL
GRAL
OSPN
OSPN
Q1 26
Q4 25
-146.5%
15.3%
Q3 25
-175.8%
15.4%
Q2 25
-217.6%
7.3%
Q1 25
-298.6%
43.8%
Q4 24
17.1%
Q3 24
-368.4%
21.4%
Q2 24
-541.7%
0.0%
Capex Intensity
GRAL
GRAL
OSPN
OSPN
Q1 26
Q4 25
0.2%
4.7%
Q3 25
1.1%
4.4%
Q2 25
1.0%
3.1%
Q1 25
0.2%
2.6%
Q4 24
3.2%
Q3 24
3.4%
3.5%
Q2 24
4.3%
3.7%
Cash Conversion
GRAL
GRAL
OSPN
OSPN
Q1 26
2.44×
Q4 25
0.29×
Q3 25
1.74×
Q2 25
0.75×
Q1 25
2.02×
Q4 24
0.43×
Q3 24
1.69×
Q2 24
0.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRAL
GRAL

Screening Revenue$42.3M97%
Developmental Services Revenue$1.3M3%

OSPN
OSPN

Product and license$35.5M54%
Services and other$30.4M46%

Related Comparisons